Efeito do praziquantel incorporado a lipossomas nos diferentes estágios de desenvolvimento dos ovos de Schistosoma mansoni

Frezza, T. F; Madi, R. R; Banin, T. M; Pinto, M. C; Souza, A. L. R; Gremião, M. P. D; Allegretti, S. M.
Rev. ciênc. farm. básica apl ; 28(2): 209-214, 2007. tab
Artigo em Português | LILACS | ID: lil-486512

Documentos relacionados

  1. Molecular and cellular basis of praziquantel action in the cardiovascular system.
  2. A single locus determines praziquantel response in <i>Schistosoma mansoni</i>.
  3. Itraconazole, a cytochrome P450 inhibitor, enhanced the efficacy of praziquantel against Schistosoma mansoni infection and alleviated liver injury in mice.
  4. Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel.
  5. Alternate-day fasting, a high-sucrose/caloric diet and praziquantel treatment influence biochemical and behavioral parameters during Schistosoma mansoni infection in male BALB/c mice.
  6. Oncolytic Myxoma virus infects and damages the tegument of the human parasitic flatworm Schistosoma mansoni.
  7. Schistosomicidal and hepatoprotective activity of gamma-aminobutyric acid (GABA) alone or combined with praziquantel against Schistosoma mansoni infection in murine model.
  8. Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis.
  9. In vitro and in vivo impacts of nifedipine and diltiazem on praziquantel chemotherapy in murine Schistosoma mansoni.
  10. Biochanin A in murine <i>Schistosoma mansoni</i> infection: effects on inflammation, oxidative stress and fibrosis.